BOLT BIOTHERAPEUTICS INC (BOLT) Stock Balance Sheet
NASDAQ:BOLT - Nasdaq - US0977021049 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.39M | 7.21M | 10.81M | 9.20M | 27.40M | |||
| Marketable Securities | 30.45M | 40.12M | 91.38M | 159.60M | 158.80M | |||
| Receivables | N/A | 1.17M | N/A | N/A | N/A | |||
| Other Current Assets | 3.67M | 2.33M | 3.52M | 3.90M | 2.90M | |||
| Total Current Assets | 42.51M | 50.81M | 105.71M | 172.70M | 189.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 23.21M | 24.89M | 24.08M | 28.50M | 30.60M | |||
| Investments And Advances | 19.11M | 22.88M | 26.41M | 23.90M | 85.30M | |||
| Other Non-Current Assets | 1.03M | 1.04M | 3.59M | 2.60M | 2.60M | |||
| Total Non-Current Assets | 43.35M | 48.82M | 54.08M | 55.10M | 118.50M | |||
| TOTAL ASSETS | 85.86M | 99.63M | 159.78M | 227.80M | 307.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 8.95M | 11.33M | 15.27M | 17.50M | 14.90M | |||
| Accounts Payable | 1.53M | 1.51M | 2.99M | 3.60M | 3.60M | |||
| Other Current Liabilities | 3.08M | 3.02M | 2.20M | 2.00M | 2.90M | |||
| Total Current Liabilities | 13.56M | 15.86M | 20.46M | 23.10M | 21.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 25.49M | 26.58M | 26.59M | 33.20M | 36.30M | |||
| Total Non-Current Liabilities | 25.49M | 26.58M | 26.59M | 33.20M | 36.30M | |||
| TOTAL LIABILITIES | 39.05M | 42.43M | 47.04M | 56.30M | 57.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -438.44M | -427.40M | -364.29M | -295.10M | -207.00M | |||
| Additional Paid In Capital | 485.21M | 484.50M | 476.99M | 467.50M | 457.40M | |||
| Common Shares | 400.00 | 400.00 | 1.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 39.60K | 96.60K | 37.00K | -900.00K | -300.00K | |||
| Shares Outstanding | 38.34M | 38.34M | 38.11M | 37.80M | 37.40M | |||
| Tangible Book Value per Share | 1.22 | 1.49 | 2.96 | 4.54 | 6.69 | |||
| Total Shareholders' Equity | 46.81M | 57.20M | 112.74M | 171.50M | 250.10M | |||
| TOTAL LIABILITIES AND EQUITY | 85.86M | 99.63M | 159.78M | 227.80M | 307.70M | |||
| Statistics | ||||||||
| Current Ratio | 3.13 | 3.20 | 5.17 | 7.48 | 8.88 | |||
| Return On Assets (ROA) | -73.78% | -63.35% | -43.31% | -38.67% | -32.04% | |||
| Return On Equity (ROE) | -135.33% | -110.35% | -61.38% | -51.37% | -39.42% | |||
All data in USD , ROIC based on taxRate of 0.21